Browsing Tag
TumoCure
1 post
UroGen takes $7m IntraGel stake as local oncology pipeline expands beyond bladder cancer
UroGen Pharma is investing up to $7 million in IntraGel Therapeutics while securing options on TumoCure and as many as three additional oncology programs built around sustained local drug delivery.